Table 2. General Hemostatic markers for the study population.
Variable | Cases ( N = 89) |
Control ( N = 77) |
---|---|---|
Mean Fib (mg/L) | 4.2 ± 0.8 | 3.1 ± 0.7** |
Mean FVII (U/dL) | 129 ± 29 | 104 ± 23** |
Mean AT (%) | 96 ± 10 | 101 ± 8* |
Mean PC (U/dL) | 116 ± 19 | 106 ± 20* |
Mean FPS (%) | 104 ± 24 | 91 ± 23* |
Median FVIII (IU/dL) | 148 (126–195) | 121 (98–144)** |
Median DD (mg/L) | 420 (315–670) | 280 (220–413)** |
Median PAI-1 (ng/mL) | 5.51 (3.19–9.11) | 1.54 (0.83–2.71)** |
Mean TFPI (ng/mL) | 14.1 ± 4.91 | 10.37 ± 4.51** |
Abbreviations: AT, antithrombin activity; DD, D-dimer; Fib, Clauss fibrinogen; FPS, free protein S; N, number; PAI-1, plasminogen activator inhibitor 1; PC, protein C activity; PLT, platelet count; TFPI, tissue factor pathway inhibitor.
Notes: Normally distributed data are presented as mean ± SD (standard deviation) and the p -values are based on independent Student's t -test. Nonnormally distributed data are presented as median (interquartile range) and p -values are based on test. Significant differences are indicated as follows: ** p < 0.001; *0.05 < p ≥ 0.001.